Cases of acute cardiovascular disease and cardiac complications caused by COVID-19 require cardiovascular imaging require cardiac imaging to continue under the pandemic. All the key cardiovascular imaging societies in March ands April issued COVID-19 guidelines and lists of considerations for how to continue imaging operations safely under the threat of viral contamination during the duration of containment efforts.


9 cardiologists from around the Unites States share COVID-19 insights
Video Player is loading.
Current Time 0:00
Duration 15:39
Loaded: 0%
Stream Type LIVE
Remaining Time 15:39
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    DAIC Editor Dave Fornell has conducted numerous video interviews remotely from his home office in March and April 2020 with nine cardiologists from around the United States. After each interview he asked how COVID-19 has impacted their hospital and them personally. This video offers a candid overview of their thoughts in the fight against the novel coronavirus.

    Each was interviewed for other videos and some of the comments used here were from a questions after the main interview on how novel coronavirus (COVID-19, SARS-CoV-2) is impacting them, their patients or their cardiology departments. 

    Insights include the following doctors. Click on the names to see their videos from March and April 2020:

       • Thomas Maddox, M.D., Washington University School of Medicine, St. Louis
       • Ehtisham Mahmud, M.D., UC San Diego Medical Center
       • William O’Neill, M.D., Henry Ford Hospital, Detroit
       • Regina Druz, M.D., Integrative Cardiology Center of Long Island, N.Y.
       • Justin Fried, M.D., Columbia University Irving Medical Center, New York City
       • Hicham Skali, M.D., Brigham and Women’s Hospital, Boston
       • Stephen Bloom, M.D., FASNC, Midwest Heart and Vascular Associates, Overland Park, Kansas
       • Michael Mack, M.D., Baylor Scott and White, Dallas, Texas
       • Basel Ramlawi, M.D, Heart and Vascular Center at Valley Health System in Virginia

    Find more videos and news on the impact of COVID-19 on cardiology

     

     

    Recent Videos View all 660 items

    January 30, 2025

    On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

    During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

    Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
     

    Company Profile

    The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

    For more information, visit optum.com.

    January 07, 2025

    On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

    Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

    In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

    Learning Objectives

    * Understand basic mechanisms of contrast induced kidney injury.
    * Determine incidence of disease along with long term patient and economic implications.
    * Review risk factors determining higher risk populations.
    * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
    * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

    Dr. Aditya Sharma
    Dr Aditya Sharma

    Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

    About ACIST

    Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

    January 01, 2025

    Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

    The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

    Learning Objectives

    By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

    • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

    • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

    • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

    Featured Speakers

    headshot

    Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

    Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



    headshot

    Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

    Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

    About ACIST

    Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

    January 24, 2025

    Behavioral science is being applied in unique ways for enterprise-imaging product design.

    Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

    In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

    Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

    By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

    Learning Objectives

    • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

    • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

    • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

    Featured Speakers

    James Stinnett

    James Stinnett, Behavioral Scientist, Change Healthcare

    James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

    Dr. Barry Bertolet

    Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

    Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

    About Change Healthcare

    Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

    Sponsored Videos View all 46 items

    Cardiovascular Ultrasound | July 20, 2022

    Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

    Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

    Cardiovascular Ultrasound | July 07, 2022

    Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

    Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

    *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

    Cardiovascular Ultrasound | June 14, 2022

    The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

    Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

    Cardiovascular Ultrasound | May 31, 2022

    Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

    Conference Coverage View all 467 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Cath Lab View all 316 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Cardiac Imaging View all 289 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Cardiac Diagnostics View all 78 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    EP Lab View all 83 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Information Technology View all 177 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care


    The provision of echocardiographic services remains crucial during the novel coronavirus (COVID-19, SARS-CoV-2) outbreak. To minimizing risks to cardiac ultrasound staff, The American Society of Echocardiography (ASE) commissioned a group of experts to a statement outlining recommendations to improve safety and reduce the potential for COVID-19 cross contamination. 



    April 14, 2020 — There is a major challenge in balancing the risk of a delaying a needed valvular and structural heart disease (SHD) procedures against the risk of a susceptible patient being brought into the hospital during the COVID-19 pandemic.



    April 14, 2020 — Since the start of COVID-19 containment efforts across the U.S. in March 2020, there has been a massive drop in the normal number of heart attack and stroke cases showing up at hospitals across the country. This has raised concerns that patients are not seeking medical attention because of fears about going to the hospital. 


    Etisham Mahmud discusses ACC and SCAI structural heart triage suggestions during COVID-19
    Video Player is loading.
    Current Time 0:00
    Duration 3:56
    Loaded: 0%
    Stream Type LIVE
    Remaining Time 3:56
     
    1x
      • Chapters
      • descriptions off, selected
      • captions off, selected
      • en (Main), selected

      Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center, explains the new American College of Cardiology (ACC) and SCAI precaution guidelines for treating transcatheter aortic valve replacement (TAVR) patients in the cath lab during the COVID-19 pandemic.

      He explains recommendations for how structural heart programs can continue to treat acutely ill patients during novel coronavirus (COVID-19, SARS-CoV-2) containment efforts. The key message in the guidelines is to defer patients who can wait until containemnt efforts loosen in the coming months, while acute patients who are very sick should be treated.

      The guidelines are outlined in the document "Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID‐19) Pandemic: An ACC /SCAI Consensus Statement." can be accessed online in the SCAI journal Catheterization and Cardiovascular Interventions.[1]

       

      Related COVID-19 Cardiology Content:

      VIDEO: Impact of COVID-19 on the Cardiovascular Program at Henry Ford Hospital — Interview with William O’Neill, M.D.

      First Large-scale U.S. Study on Hydroxychloroquine COVID-19 Prophylaxis Begins in Detroit

      New York City Physicians Note Multiple Cardiovascular Presentations of COVID-19

      VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — Interview with Ehtisham Mahmud, M.D.

      ACC COVID-19 recommendations for the cardiovascular care team

      VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

      AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients

      FDA Approves ECMO to Treat COVID-19 Patients

      COVID-19 STEMI Registry Created to Study Acute Cardiovascular Effects of the Virus

      Image Gallery Showing Impact of the COVID-19 Pandemic

      VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic

      The Cardiac Implications of Novel Coronavirus

       

       

      Reference:

      1. Pinak B. Shah, Frederick G.P. Welt, Ehtisham Mahmud, et al. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID‐19) Pandemic: An ACC /SCAI Consensus Statement. Catheterization and Cardiovascular Interventions. First published:06 April 2020 https://doi.org/10.1002/ccd.28910.

      Recent Videos View all 660 items

      January 30, 2025

      On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

      During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

      Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
       

      Company Profile

      The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

      For more information, visit optum.com.

      January 07, 2025

      On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

      Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

      In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

      Learning Objectives

      * Understand basic mechanisms of contrast induced kidney injury.
      * Determine incidence of disease along with long term patient and economic implications.
      * Review risk factors determining higher risk populations.
      * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
      * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

      Dr. Aditya Sharma
      Dr Aditya Sharma

      Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

      About ACIST

      Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

      January 01, 2025

      Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

      The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

      Learning Objectives

      By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

      • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

      • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

      • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

      Featured Speakers

      headshot

      Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

      Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



      headshot

      Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

      Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

      About ACIST

      Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

      January 24, 2025

      Behavioral science is being applied in unique ways for enterprise-imaging product design.

      Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

      In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

      Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

      By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

      Learning Objectives

      • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

      • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

      • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

      Featured Speakers

      James Stinnett

      James Stinnett, Behavioral Scientist, Change Healthcare

      James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

      Dr. Barry Bertolet

      Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

      Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

      About Change Healthcare

      Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

      Sponsored Videos View all 46 items

      Cardiovascular Ultrasound | July 20, 2022

      Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

      Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

      Cardiovascular Ultrasound | July 07, 2022

      Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

      Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

      *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

      Cardiovascular Ultrasound | June 14, 2022

      The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

      Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

      Cardiovascular Ultrasound | May 31, 2022

      Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

      Conference Coverage View all 467 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cath Lab View all 316 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cardiac Imaging View all 289 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cardiac Diagnostics View all 78 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      EP Lab View all 83 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Information Technology View all 177 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care


      In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), the DAIC editorial team will be providing regular recaps of pertinent information.


      William O'Neill explains hydroxychloroquine trial in Detroit
      Video Player is loading.
      Current Time 0:00
      Duration 9:04
      Loaded: 0%
      Stream Type LIVE
      Remaining Time 9:04
       
      1x
        • Chapters
        • descriptions off, selected
        • captions off, selected
        • en (Main), selected

        Cardiologist William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit, is organizing COVID-19 clinical trials in Detroit with cardiologists at four hospitals. With cardiac trial enrollments at a standstill, Henry Ford's cardiology department offered its research capabilities in the fight against COVID-19.

        The collaboration initiated its first 3,000 patient trials April 9 to test if hydroxychloroquine help prevent the onset of COVID-19 in front-line clinicians, first responders and other essential workers. can to bring large-scale novel coronavirus (COVID-19, SARS-CoV-2) drug trials to southeast Michigan. 

        Four metropolitan Detroit hospital systems and a leading research university, Henry Ford Health System, Ascension, Detroit Medical Center (DMC), Beaumont and Wayne State University, are collaborating to bring large-scale COVID-19 drug trials to southeast Michigan.

        The current WHIP COVID-19 Trial will include three arms in this randomized, blinded trial testing safety and efficacy of hydroxychloroquine in first-responder and front-line healthcare workers. They will be divided into a low-dose arm, high-dose arm and a placebo arm. 

        Read more about the trials in the article First Large-scale U.S. Study on Hydroxychloroquine COVID-19 Prophylaxis Begins in Detroit

        Read more about O'Neill and other cardiologists heading the COVID-19 trial collaboration.

        Read the FDA document on the trial

         

        Related COVID-19 Cardiology Content:

        VIDEO: Overview of Hydroxychloroquine and FDA Warning in its use to Treat COVID-19 — Interveiew with Marianne Pop, Pharm.D.

        FDA Reports of Deaths and Injuries From Use of Antimalarial hydroxychloroquine in COVID-19 Patients

        VIDEO: Cardiologists Manage Trial Testing if Hydroxychloroquine Protects Clinicians From COVID-19 — Interview with Bill O'Neill, M.D.

        FDA Reports of Deaths and Injuries From Use of Antimalarial Drugs in COVID-19 Patients

        New York City Physicians Note Multiple Cardiovascular Presentations of COVID-19

        AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients

        FDA Approves ECMO to Treat COVID-19 Patients

        COVID-19 STEMI Registry Created to Study Acute Cardiovascular Effects of the Virus

        Image Gallery Showing Impact of the COVID-19 Pandemic

        VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic

        VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — Interview with Ehtisham Mahmud, M.D.

        ACC COVID-19 recommendations for the cardiovascular care team

        VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

        The Cardiac Implications of Novel Coronavirus

         

        Recent Videos View all 660 items

        January 30, 2025

        On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

        During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

        Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
         

        Company Profile

        The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

        For more information, visit optum.com.

        January 07, 2025

        On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

        Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

        In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

        Learning Objectives

        * Understand basic mechanisms of contrast induced kidney injury.
        * Determine incidence of disease along with long term patient and economic implications.
        * Review risk factors determining higher risk populations.
        * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
        * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

        Dr. Aditya Sharma
        Dr Aditya Sharma

        Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

        About ACIST

        Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

        January 01, 2025

        Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

        The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

        Learning Objectives

        By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

        • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

        • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

        • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

        Featured Speakers

        headshot

        Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

        Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



        headshot

        Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

        Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

        About ACIST

        Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

        January 24, 2025

        Behavioral science is being applied in unique ways for enterprise-imaging product design.

        Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

        In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

        Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

        By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

        Learning Objectives

        • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

        • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

        • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

        Featured Speakers

        James Stinnett

        James Stinnett, Behavioral Scientist, Change Healthcare

        James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

        Dr. Barry Bertolet

        Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

        Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

        About Change Healthcare

        Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

        Sponsored Videos View all 46 items

        Cardiovascular Ultrasound | July 20, 2022

        Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

        Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

        Cardiovascular Ultrasound | July 07, 2022

        Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

        Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

        *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

        Cardiovascular Ultrasound | June 14, 2022

        The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

        Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

        Cardiovascular Ultrasound | May 31, 2022

        Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

        Conference Coverage View all 467 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        Cath Lab View all 316 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        Cardiac Imaging View all 289 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        Cardiac Diagnostics View all 78 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        EP Lab View all 83 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        Information Technology View all 177 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        William O'Neill discusses COVID-19 impact on cardiology at Henry Ford Hospital
        Video Player is loading.
        Current Time 0:00
        Duration 4:59
        Loaded: 0%
        Stream Type LIVE
        Remaining Time 4:59
         
        1x
          • Chapters
          • descriptions off, selected
          • captions off, selected
          • en (Main), selected

          Detroit, Michigan, has been one the hardest hit regions with a large number of COVID-19 cases. William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, explains the impact of novel coronavirus (COVID-19, SARS-CoV-2) on the cardiology program and his takeaways on COVID-19 cardiovascular involvement based on cases he has seen.

          O'Neill said ST-elevated myocardial infarction (STEMI) cases have mysteriously dropped off significantly since quarantines began, a reflection of a nationwide trend. He also said he has not seen a lot of myocarditis or cardiogenic shock COVID-19 patients, except for a small handful. These conditions have been reported elsewhere in COVID-19 patients, but O'Neill said the patients he has seen die of COVID-19 usually have an onset of a cytokine storm, lose vascular integrity and then all their organs fail. He has not seen a primary cardiac component involved in most of the critically ill patients where hemodynamic support would have helped. 

           

          Related COVID-19 Cardiology Content:

          First Large-scale U.S. Study on Hydroxychloroquine COVID-19 Prophylaxis Begins in Detroit

          New York City Physicians Note Multiple Cardiovascular Presentations of COVID-19

          AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients

          FDA Approves ECMO to Treat COVID-19 Patients

          COVID-19 STEMI Registry Created to Study Acute Cardiovascular Effects of the Virus

          Image Gallery Showing Impact of the COVID-19 Pandemic

          VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic

          VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — Interview with Ehtisham Mahmud, M.D.

          ACC COVID-19 recommendations for the cardiovascular care team

          VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

          The Cardiac Implications of Novel Coronavirus

           

           

          Recent Videos View all 660 items

          January 30, 2025

          On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

          During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

          Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
           

          Company Profile

          The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

          For more information, visit optum.com.

          January 07, 2025

          On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

          Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

          In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

          Learning Objectives

          * Understand basic mechanisms of contrast induced kidney injury.
          * Determine incidence of disease along with long term patient and economic implications.
          * Review risk factors determining higher risk populations.
          * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
          * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

          Dr. Aditya Sharma
          Dr Aditya Sharma

          Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

          About ACIST

          Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

          January 01, 2025

          Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

          The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

          Learning Objectives

          By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

          • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

          • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

          • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

          Featured Speakers

          headshot

          Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

          Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



          headshot

          Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

          Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

          About ACIST

          Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

          January 24, 2025

          Behavioral science is being applied in unique ways for enterprise-imaging product design.

          Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

          In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

          Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

          By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

          Learning Objectives

          • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

          • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

          • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

          Featured Speakers

          James Stinnett

          James Stinnett, Behavioral Scientist, Change Healthcare

          James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

          Dr. Barry Bertolet

          Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

          Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

          About Change Healthcare

          Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

          Sponsored Videos View all 46 items

          Cardiovascular Ultrasound | July 20, 2022

          Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

          Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

          Cardiovascular Ultrasound | July 07, 2022

          Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

          Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

          *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

          Cardiovascular Ultrasound | June 14, 2022

          The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

          Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

          Cardiovascular Ultrasound | May 31, 2022

          Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

          Conference Coverage View all 467 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cath Lab View all 316 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cardiac Imaging View all 289 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cardiac Diagnostics View all 78 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          EP Lab View all 83 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Information Technology View all 177 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care


          April 10, 2020 — Enrollment began April 9 at Henry Ford Hospital for the first large-scale study in the United States of the effectiveness of the anti-malarial drug hydroxychloroquinein in preventing COVID-19 in healthcare workers and first responders who volunteer to participate.

          In less than a day the study already had more than 1,000 volunteers enroll. Interim results are expected in 30 days and final results of this lighting-speed trial will be available by this summer.


          Subscribe Now